Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck

AD Colevas - Journal of Clinical Oncology, 2006 - ascopubs.org
The purpose of this review is to provide readers with guidance concerning treatment of
patients with advanced, recurrent or metastatic squamous cell carcinoma of the head and …

[HTML][HTML] Fatigue in cancer patients receiving chemotherapy: an analysis of published studies

A Iop, AM Manfredi, S Bonura - Annals of oncology, 2004 - Elsevier
Fatigue is a subjective experience that affects everybody. In healthy individuals, it can be
considered a physiological response to physical or psychological stress. In people with …

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

MR Posner, DM Hershock, CR Blajman… - … England Journal of …, 2007 - Mass Medical Soc
Background A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the
head and neck compared induction chemotherapy with docetaxel plus cisplatin and …

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation

Y Pointreau, P Garaud, S Chapet, C Sire… - Journal of the …, 2009 - academic.oup.com
Background Chemotherapy with cisplatin (P) and 5-fluorouracil (F) followed by radiotherapy
in patients who respond to chemotherapy is an alternative to total laryngectomy for patients …

A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma

M Hareyama, K Sakata, H Shirato, T Nishioka… - Cancer, 2002 - Wiley Online Library
BACKGROUND A prospective, randomized study was performed to determine the efficacy of
neoadjuvant chemotherapy over radiotherapy alone in patients with locally advanced …

Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up

PL Zorat, A Paccagnella, G Cavaniglia… - Journal of the …, 2004 - academic.oup.com
In 1986, we initiated a multicenter, randomized trial to compare induction chemotherapy with
cisplatin and 5-fluorouracil followed by locoregional treatment (surgery and radiotherapy or …

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for …

EE Vokes, K Stenson, FR Rosen, MS Kies… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: The paclitaxel, fluorouracil, and hydroxyurea regimen of paclitaxel, infusional
fluorouracil, hydroxyurea, and twice-daily radiation therapy (TFHX) administered every other …

Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and …

MR Posner, B Glisson, G Frenette… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: We conducted a phase I-II, multi-institutional trial to determine the maximum-
tolerated dose (MTD) of cisplatin in an induction chemotherapy regimen of docetaxel …

[HTML][HTML] End points for new agents in induction chemotherapy for locally advanced head and neck cancers

C Monnerat, S Faivre, S Temam, J Bourhis… - Annals of …, 2002 - Elsevier
More than 60% of patients diagnosed with squamous cell carcinoma of the head and neck
present at a locally advanced stage. Although multimodality therapy has improved …

Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck

AD Colevas, R Read, J Thornhill, S Adak… - International Journal of …, 2001 - Elsevier
Purpose: Treatment of head-and-neck cancer patients with surgery, radiotherapy (RT), and
chemotherapy has been associated with posttherapy hypothyroidism (HT). We evaluated the …